Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

EXPLAINED: Leroy leo - The Real Truth

Nvidia pauses revenue-sharing deals with AI cloud companies

The chip giant stepped back from the program last week, the Journal said, adding that it could still revamp the initiative later or fold it into another program.

The Economic Times

Broadcom seeks more than $60 billion in latest AI debt deal

Broadcom seeks more than $60 billion in latest AI debt deal

The numbers under discussion would potentially bring the total raise to as much as $100 billion, according to the report.

The Economic Times

Anthropic revenue run rate tops $65 billion

Anthropic revenue run rate tops $65 billion

The ‌AI startup's ⁠latest ⁠revenue run rate - a metric that projects annual performance by extrapolating current sales levels - was up from the $47 billion in May and an extraordinary jump from about $9 billion at the end of 2025.

The Economic Times

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Micron, Anthropic sign AI infrastructure supply agreement

Micron Technology has partnered with AI innovator Anthropic, providing integral memory and storage solutions while also investing in its forthcoming IPO. This strategic collaboration is designed to enhance the development of Anthropic's Claude models by refining memory and storage capabilities. Following a substantial funding round, Anthropic has filed for an…

The Economic Times

Marvell to join S&P 500 after AI boom helps chipmaker pass profitability test

The company will replace swimming pool equipment distributor PoolCorp on the benchmark index before the start of trading on ‌June 22. Marvell ⁠shares ⁠jumped nearly 6% in extended trading.

The Economic Times

FDA advisers back the same COVID vaccine for initial shots, boosters

Advisers to the U.S. Food and Drug Administration on Thursday unanimously voted in favor of targeting the same coronavirus strain for initial COVID-19 vaccine doses and boosters going forward, but some expressed skepticism about whether all Americans need to receive the shots annually.

U.S. extends public health emergency status for COVID

The U.S. health department on Wednesday extended the COVID-19 pandemic's status as a public health emergency, allowing millions of Americans to continue receiving free tests, vaccines and treatments.

inkl

Read news from The Economist, FT, and more,
with one subscription

J&J and Merck Ebola vaccines produce lasting antibodies in children and adults -studies

J&J and Merck Ebola vaccines produce lasting antibodies in children and adults -studies

Ebola vaccines developed by Johnson Johnson and Merck Co produced virus-fighting antibodies and appear to be safe in children and adults, according to data from two studies published on Wednesday.

Malaria deaths dip in 2021 after rising in first year of COVID, says WHO

Malaria deaths dip in 2021 after rising in first year of COVID, says WHO

Malaria-related deaths fell slightly in 2021 after a significant increase in the first year of COVID-19, but remained higher than the pre-pandemic estimated toll, according to a World Health Organization (WHO) report on Thursday.

EU secures up to 2 million monkeypox vaccine doses from Bavarian Nordic

EU secures up to 2 million monkeypox vaccine doses from Bavarian Nordic

The European Union said on Thursday it had secured supply of up to 2 million doses of a monkeypox vaccine from Danish company Bavarian Nordic for the next two years.

Rash of child deaths in Gambia linked to cough syrups made in India -WHO

Rash of child deaths in Gambia linked to cough syrups made in India -WHO

The deaths of dozens of young children in Gambia from acute kidney injuries may be linked to contaminated cough and cold syrups made by an Indian drug manufacturer, the World Health Organization said on Wednesday.

Medical device makers see little impact from Fiona on Puerto Rico operations

Medical device makers see little impact from Fiona on Puerto Rico operations

Medical device companies and some drugmakers with manufacturing operations in Puerto Rico said they do not expect meaningful disruption from Hurricane Fiona, which knocked out power for over 3 million people and caused flooding and landslides on the island.

1

People

RICARDO ARDUENGO

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

World Health Organization

Johnson & Johnson (

Micron Technology

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

415,899 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play